Research establishes foundation for clinical experiment targeted at averting brain tumours in kids with NF1.
FDA
Casgevy, one of these treatments, is the first FDA-approved medication to make use of a revolutionary form of genome editing technique
The first oral drug suggested to treat postpartum depression (PPD) in adults, Zurzuvae (zuranolone), has received approval from the U.S. Food and Drug Administration. PPD is a significant depressive episode that can start later in pregnancy but usually starts after delivery. Until recently, the only form of therapy for PPD […]
